CD19-CAR.CD45RA- negative T-cells / St. Jude Children's Research Hospital - LARVOL DELTA

Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia (clinicaltrials.gov) - P1 | N=60 | Recruiting | Sponsor: St. Jude Children's Research Hospital | Trial completion date: Jun 2027 ➔ Jul 2028 | Trial primary completion date: Jun 2026 ➔ Jul 2027

Trial completion date • Trial primary completion date • Acute Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Oncology • Pediatrics

Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia (clinicaltrials.gov) - P1 | N=60 | Recruiting | Sponsor: St. Jude Children's Research Hospital | Trial completion date: Jan 2026 ➔ Jun 2027 | Trial primary completion date: Jan 2025 ➔ Jun 2026

Trial completion date • Trial primary completion date • Acute Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Oncology • Pediatrics

Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia (clinicaltrials.gov) - P1; N=60; Recruiting; Sponsor: St. Jude Children's Research Hospital

Clinical • New P1 trial • Acute Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Oncology • Pediatrics • CD19